VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $97 | +73.2% | 10,096 | +81.7% | 0.00% | -33.3% |
Q4 2023 | $56 | -17.6% | 5,555 | -23.2% | 0.00% | 0.0% |
Q3 2023 | $68 | -62.2% | 7,231 | -1.5% | 0.00% | -57.1% |
Q2 2023 | $180 | +4.7% | 7,344 | -0.6% | 0.01% | 0.0% |
Q1 2023 | $172 | -8.5% | 7,386 | -0.4% | 0.01% | -12.5% |
Q4 2022 | $188 | -99.9% | 7,412 | -16.9% | 0.01% | +14.3% |
Q3 2022 | $172,000 | -40.1% | 8,917 | -20.8% | 0.01% | -12.5% |
Q2 2022 | $287,000 | +282.7% | 11,253 | +283.7% | 0.01% | +300.0% |
Q1 2022 | $75,000 | -46.8% | 2,933 | -12.8% | 0.00% | -33.3% |
Q4 2021 | $141,000 | -2.8% | 3,362 | +0.8% | 0.00% | 0.0% |
Q3 2021 | $145,000 | -11.0% | 3,336 | -3.5% | 0.00% | 0.0% |
Q2 2021 | $163,000 | – | 3,456 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $39,700,000 | 30.52% |
SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $565,858,000 | 4.50% |
Zebra Capital Management LLC | 25,419 | $647,000 | 1.90% |
Alaska Permanent Fund Corp | 2,300,000 | $58,581,000 | 0.84% |
CLARK ESTATES INC/NY | 180,000 | $4,585,000 | 0.79% |
Temasek Holdings (Private) Ltd | 5,602,553 | $142,697,025 | 0.78% |
SECTOR GAMMA AS | 110,223 | $2,807,000 | 0.63% |
Avidity Partners Management LP | 758,211 | $19,312,000 | 0.44% |
New Vernon Capital Holdings II LLC | 14,501 | $369,000 | 0.30% |
DUALITY ADVISERS, LP | 116,415 | $2,965,000 | 0.29% |